Central Role of Transforming Growth Factor Type Beta 1 in Skeletal Muscle Dysfunctions: An Update on Therapeutic

Johanna Abrigo1,2, Felipe Simon2,3, Daniel Cabrera4,5

  • 1Laboratory of Muscle Pathology, Fragility and Aging, Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas & Facultad de Medicina, Universidad Andres Bello, Santiago, Chile.

Insights

Transforming Growth Factor Beta 1 (TGF-β1) inhibits muscle regeneration and promotes fibrosis and atrophy. This review explores TGF-β1

Area of Science:

  • Muscle physiology and pathology
  • Cellular biology
  • Regenerative medicine

Background:

  • Transforming Growth Factor Beta 1 (TGF-β1) is a key regulator of skeletal muscle function.
  • TGF-β1 plays a critical role in inhibiting myogenesis and regeneration.
  • It is implicated in muscle pathologies characterized by fibrosis and atrophy.

Purpose of the Study:

  • To review the mechanisms and cellular targets of TGF-β1 in skeletal muscle.
  • To discuss the role of TGF-β1 in muscle regeneration inhibition, fibrosis, and atrophy.
  • To provide an update on therapeutic strategies targeting TGF-β1's detrimental effects.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of cellular and molecular mechanisms.
  • Synthesis of current therapeutic approaches.

Main Results:

  • TGF-β1 signaling negatively impacts satellite cell activity and function.
  • The factor is a central mediator in the development of muscle fibrosis and atrophy.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Conclusions:

  • TGF-β1 is a significant detrimental factor in skeletal muscle pathologies.
  • Inhibiting TGF-β1's deleterious actions holds therapeutic potential for muscle diseases.
  • Further research into TGF-β1 inhibition strategies is warranted.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.6K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.4K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.2K
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
6.1K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.3K